| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 09/04/2008 | US20080214676 N-(1-cyanocyclopropyl)-4,4-difluoro-2(S)-[2,2,2-trifluoro-1(S)-(4-fluorophenyl)ethylamino)octamide; rheumatoid arthritis, multiple sclerosis, myasthenia gravis, psoriasis, pemphigus vulgaris, Graves' disease, myasthenia gravis, lupus, asthma, pain, atherosclerosis; cathepsins B, K, L, F, and S inhibitors |
| 09/04/2008 | US20080214674 Acylhydrazone derivatives and the use thereof in the inhibition, regulation and/or modulation of kinase signal transduction |
| 09/04/2008 | US20080214668 Use of retinoids to treat high blood pressure and other cardiovascular disease |
| 09/04/2008 | US20080214663 Levodopa dimethyl-substituted diester prodrugs compositions, and methods of use |
| 09/04/2008 | US20080214660 Compounds and Methods for the Inhibition of the Expression of VCAM-1 |
| 09/04/2008 | US20080214652 Methods of treating hyperlipidemia |
| 09/04/2008 | US20080214650 crystalline polymorphic dosage forms of anticholesterol agents; statins; small particle size distribution |
| 09/04/2008 | US20080214638 To treat diseases of lipid metabolism, cardiovascular disease, inflammatory diseases; selective agonists of the nicotinic acid receptor; 2-{[(4-Biphenylyloxy)acetyl]amino}-4-(methyloxy)benzoic acid |
| 09/04/2008 | US20080214637 use of catalytic amounts of organic acids to prepare losartan, irbesartan and olmesartan medoxomil or their salts, and candesartan cilexetil |
| 09/04/2008 | US20080214626 Methods for prevention and treatment of diseases causes by hypertension |
| 09/04/2008 | US20080214623 N-(2,2-Dimethylpropyl)-6-{3-fluoro-5-[(3-isoxazolylamino)carbonyl]-2-methylphenyl}-3-pyridinecarboxamide; inhibitors of p38 kinase |
| 09/04/2008 | US20080214599 Use of Par-1/Par-4 Inhibitors for Treating or Preventing Vascular Diseases |
| 09/04/2008 | US20080214598 Novel Piperidine Carboxylic Acid Amide Derivatives |
| 09/04/2008 | US20080214597 Tricyclic Lactam Derivatives as 11-Beta Hydroxysteroid Dehydrogenase Inhibitors |
| 09/04/2008 | US20080214595 Use Of Rapamycin Derivatives For The Treatment And/Or Prevention Of Cardiovas Cular Disorders |
| 09/04/2008 | US20080214578 2R)-2-[(2-amino-5-{[(1S)-1-(2-fluorophenyl)ethyl]thio}[1,3]thiazolo[4,5-d]pyrimidin-7-yl)amino]pentan-1-ol; neurodegenerative disorders, demyelinating disease, cardio- and cerebrovascular atherosclerotic disorders, peripheral artery disease, rheumatoid arthritis, pulmonary diseases su COPD, asthma |
| 09/04/2008 | US20080214556 Stabilizing with intravenous infusion followed by oral sustained release maintenance formulation; reducing blood plasma HbA1x levels |
| 09/04/2008 | US20080214554 Methods for preventing or treating cardiac arrhythmia |
| 09/04/2008 | US20080214523 Method for treating severe heart failure and medicament therefor |
| 09/04/2008 | US20080214517 Modulation of the Expression of Estrogen Receptors for the Prevention or Treatment of Heart Disease |
| 09/04/2008 | US20080214499 Lowering lipids in a living body by use of a cyclic tetrasaccharide represented by formula of cyclo{>6)- alpha -D-glucopyranosyl-(1>3)- alpha -D-glucopyranosyl-(1>6)- alpha -D-glucopyranosyl-(1>3)- alpha -D-glucopyranosyl-(1>}, and/or glycosylated compound(s) thereof |
| 09/04/2008 | US20080214495 Heterocyclic Sulfonamide Derivatives as Inhibitors of Factor Xa |
| 09/04/2008 | US20080214493 Use of Flavone Compounds as Potassium Channel Inhibitors |
| 09/04/2008 | US20080214492 Treating inflammation, oxidative stress, glycation/dysinsulinemia, platelet function, homocysteine levels and acetylcholinesterase inhibition; Alzheimer's disease; Parkinson's disease; cardiovascular diseases arterosclerosis and risk factors thereof including elevated cholesterol and blood pressure |
| 09/04/2008 | US20080214457 Isolated peptide, polynucleotide that encodes a peptide that is from 10 to 100 amino acids in length |
| 09/04/2008 | US20080213405 Pharmaceutical compositions containing bulbophyllum and their use for treating illnesses |
| 09/04/2008 | US20080213403 Method for treating pulmonary disease states in mammals by altering indigenous in vivo levels of nitric oxide |
| 09/04/2008 | US20080213396 Treating, preventing anthracycline induced myocardial fibrosis; copper lowering agent is a tetrathiomolybdate, zinc, trientine, d-penicillamine, clioquinoil and tetrathiotungstate |
| 09/04/2008 | US20080213378 Atorvastatin; lovastatin; a keto analog of mevinolin; pravastatin; simvastatin; velostatin; fluindostatin; cetyl pyridinium, polymer, biopolymer surface stabilizers; suspensions, gels, aerosols, ointments, creams, controlled release; oral, pulmonary, rectal, opthalmic; improved pharmacokinetic profiles |
| 09/04/2008 | US20080213369 Synthetic platelets |
| 09/04/2008 | US20080213362 Diuretic treatment of edema and congestive heart failure; thiazolidinedione anti-diabetic agent, pioglitazone and rosiglitazone; three layered tablet; not worsen blood sugar levels or glycemic status; dose of about 2 mg or less of torsemide |
| 09/04/2008 | US20080213351 Compositions and methods for dosing liposomes of certain sizes to treat or prevent disease |
| 09/04/2008 | US20080213348 Nucleic acid encoding protein effective as hepatocyte growth factor; reducing brain damage caused by cerebral ischemic reperfusion injuries |
| 09/04/2008 | US20080213272 Vegf-related protein |
| 09/04/2008 | US20080213253 Combination therapy for the treatment of cancer |
| 09/04/2008 | US20080213235 Adipose Tissue Stem Cells, Perivascular Cells and Pericytes |
| 09/04/2008 | US20080213234 Use of osteopontin for the treatment and/or prevention of neurologic diseases |
| 09/04/2008 | US20080213231 Self-renewing progenitor cells for use in treating cardiac disease; tissue engineering; tissue repair; regenerative medicine |
| 09/04/2008 | US20080213230 Pluripotent cell culture for propagation of cardiac tissues and treatment of myocardial infarction; tissue engineering; tissue repair; regenerative medicine |
| 09/04/2008 | US20080213226 Using nitrosomonas mixture in powder, cream, stick and/or salve to oxidize nitric oxide and nitric oxide precursors in order to treat and/or prevent vascular, nervous system, blood and eating disorders |
| 09/04/2008 | US20080213214 Treating Cardiovascular Tissue |
| 09/04/2008 | US20080213165 Caffeine, partial A2A receptor agonist; caffeine consumption prior to pharmacologic stress testing with an A2A adenosine receptor agonist abbreviate the duration of coronary vasodilation caused by the drug. |
| 09/04/2008 | DE202008006708U1 Kombination von Tocotrienolen mit langkettigen Fettsäuren für Gesunderhaltung, Schmerzlinderung und Entzündungshemmung Combination of tocotrienols with long-chain fatty acids for healthy, relieve pain and inflammation |
| 09/04/2008 | DE102007003524A1 Arzneimittel zur Behandlung und/oder Prävention von Arteriosklerose Drugs for the treatment and / or prevention of arteriosclerosis |
| 09/04/2008 | CA2679416A1 Combination therapy, composition and methods for the treatment of cardiovascular disorders |
| 09/04/2008 | CA2679266A1 Pharmaceutical composition comprising anti-grp78 antibody as active ingredient |
| 09/04/2008 | CA2679178A1 Compositions and methods for treating peripheral vascular diseases |
| 09/04/2008 | CA2679126A1 Macrocyclic compound |
| 09/04/2008 | CA2678735A1 Novel pyrrole derivative having ureido group and aminocarbonyl group as substituents |
| 09/04/2008 | CA2678097A1 New use of nitrites and nitrates and compositions containing these |
| 09/03/2008 | EP1964849A2 Transfection complexes |
| 09/03/2008 | EP1964845A1 New thiophen glycoside derivatives, method for their manufacture, medicines containing these compounds and their application |
| 09/03/2008 | EP1964844A1 New thiophen glycoside derivatives, method for their manufacture, medicines containing these compounds and their application |
| 09/03/2008 | EP1964841A1 Imidazo[1,2-a]azine and their use as pharmaceuticals |
| 09/03/2008 | EP1964840A1 Imidazo[1,2-a]pyridines and their use as pharmaceuticals |
| 09/03/2008 | EP1964839A2 Quinazoline derivatives as kinase inhibitors |
| 09/03/2008 | EP1964568A1 Utilization of hypertension/hypercardia-preventing effect of d-allose |
| 09/03/2008 | EP1964563A1 Pharmaceutical compositions containing calcium antagonist substances combined with platelet aggregation inhibiting agents for use in systemic arterial hypertension and for the prevention of ischemic vascular events |
| 09/03/2008 | EP1964561A1 Inhibitors of IMPDH enzyme |
| 09/03/2008 | EP1963360A1 Neuregulin variants and methods of screening and using thereof |
| 09/03/2008 | EP1963280A1 2 -phenylethylamino derivatives as calcium and/or sodium channel modulators |
| 09/03/2008 | EP1962888A2 Uses for camkii and hdacs in the treatment of heart conditions |
| 09/03/2008 | EP1962858A1 Phytosterols for use in reducing c-reactive protein levels |
| 09/03/2008 | EP1962856A2 Medicament based on a monoester of steroids with long chain fatty acids |
| 09/03/2008 | EP1962840A1 Use of 4, 7-dihydrothieno [2, 3-b]pyridine compounds in the treatment of cardiovascular diseases |
| 09/03/2008 | EP1962825A2 Use of dha, epa or dha-derived epa for treating a pathology associated with cellular oxidative damage |
| 09/03/2008 | EP1701933B1 Novel compounds |
| 09/03/2008 | EP1480647B1 Mono-ester and asymmetrically substituted di-ester pro-drugs of the dopamine d1 receptor agonists |
| 09/03/2008 | EP1465626B1 Pharmaceutical compositions (kit) comprising dihydropyridinone compounds and an immunoregulatory (or an antiinflammatory) agent and their uses |
| 09/03/2008 | EP1343781B1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 09/03/2008 | EP1328289B1 Oxidized proteins, their biological activity, and therapeutic and diagnostic measures, which are derived from the active mechanism, from the use of these proteins or from the inhibition thereof |
| 09/03/2008 | EP1311708B1 Method for identifying substances useful for treating inflammation using the response element to the ikappabaplha ror receptor |
| 09/03/2008 | EP1311480B1 New amidino derivatives and their use as thrombin inhibitors |
| 09/03/2008 | EP1299424B1 COLD WATER SOLUBLE $g(b)-GLUCAN PRODUCT AND PROCESS FOR PREPARING THE SAME |
| 09/03/2008 | EP1261349B1 Compounds with chelation affinity and selectivity for first transition series elements and their use |
| 09/03/2008 | EP1192279B1 Diagnostics for fragile plaque disorder |
| 09/03/2008 | EP1126869B1 Methods for regulating angiogenesis and vascular integrity using the trk receptor ligands bdnf, nt-3 and nt-4 |
| 09/03/2008 | EP1121129B1 METHOD FOR TREATING DIABETES EMPLOYING AN aP2 INHIBITOR AND ASSOCIATED COMBINATIONS |
| 09/03/2008 | EP0710116B1 Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells |
| 09/03/2008 | CN101257947A Pyridylsulfonamidyl-pyrimidines for the prevention of blood vessel graft failure |
| 09/03/2008 | CN101257946A Pharmaceutical dosage form containing an active principle combination of nifedipine and/or nisoldipine and of an angiotensin ii antagonist |
| 09/03/2008 | CN101257915A Method of inhibiting angiogenesis by using ephrin B2 |
| 09/03/2008 | CN101257910A Cholesterol absorption inhibitor |
| 09/03/2008 | CN101257909A Core 2 glcnac-t inhibitors |
| 09/03/2008 | CN101257901A Use of soluble guanylate cyclase activators for treating reperfusion damage |
| 09/03/2008 | CN101257900A Gsk-3 inhibitors |
| 09/03/2008 | CN101255199A Method for extracting Siberian solomonseal rhizome polysaccharide from siberian solomonseal rhizome |
| 09/03/2008 | CN101255178A C-glycoside and C-glycoside compound containing substituted aromatic rings as well as preparation and use thereofb |
| 09/03/2008 | CN101255162A Adenosine receptor antagonists and methods of making and using the same |
| 09/03/2008 | CN101255149A 7,4'-di(mono succinate)o-ethoxy-daidzein and novel medical uses thereof |
| 09/03/2008 | CN101255135A Optical isomer of tilisolol as well as preparation method and medical use thereof |
| 09/03/2008 | CN101255116A Novel unsaturated fatty acid derivatives as well as preparation method and medicament uses thereof |
| 09/03/2008 | CN101254297A Heart nourishing preparations for curing cardiopalmus symptoms caused by sufficient heart blood |
| 09/03/2008 | CN101254284A Rheumatism treating medicine combination, preparation and quality control method |
| 09/03/2008 | CN101254266A Cardiac and cerebral vascular disease treating medicine |
| 09/03/2008 | CN101254259A Traditional Chinese medicine preparation for curing cerebrovascular disease and preparation |
| 09/03/2008 | CN101254248A Applications of Chinese medicinal composition for preparing medicament for curing chronic fatigue syndrome medicament |
| 09/03/2008 | CN101254230A Shuxiong dropping pill. and method of preparing the same |
| 09/03/2008 | CN101254220A Production process of water soluble ginkgo leaf extractive |
| 09/03/2008 | CN101254194A Applications of panax saponin-Re in neurocyte protection |